In Vitro Diagnosis of Fibrinolysis: Present Status and Desired Improvements
- 17 December 1992
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 667 (1) , 291-304
- https://doi.org/10.1111/j.1749-6632.1992.tb51630.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological SignificanceAnnals of the New York Academy of Sciences, 1992
- The Role of Protected Extracellular Compartments in Interactions between Leukocytes, and Platelets, and Fibrin/Fibrinogen MatricesaAnnals of the New York Academy of Sciences, 1992
- Clearance of Plasminogen Activators—A Major Determinant of Plasma Concentration: Therapeutic and Diagnostic ImplicationsAnnals of the New York Academy of Sciences, 1992
- Possibilities and Limitations of Reaction Product AnalysisAnnals of the New York Academy of Sciences, 1992
- Influence of platelet size on outcome after myocardial infarctionThe Lancet, 1991
- Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyJournal of the American College of Cardiology, 1991
- Hemostasis and Fibrinolysis in Severe Liver Failure and Their Relation to HemorrhageHepatology, 1986
- Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.Circulation, 1985
- THE PHENOMENON OF THE ACUTE PHASE RESPONSE*Annals of the New York Academy of Sciences, 1982
- Relative proteolysis of the fibrinogen Bβ chain by thrombin and plasmin as a determinant of thrombosisNature, 1981